Literature DB >> 17142570

My approach to pathology of the pituitary gland.

N Y Y Al-Brahim1, S L Asa.   

Abstract

The sellar region is the site of a large number of pathological entities arising from the pituitary and adjacent anatomical structures, including brain, blood vessels, nerves and meninges. The surgical pathology of this area requires the accurate identification of neoplastic lesions, including pituitary adenoma and carcinoma, craniopharyngioma, neurological neoplasms, germ cell tumours, haematological malignancies and metastases, as well as non-neoplastic lesions such as cysts, hyperplasias and inflammatory disorders. This review provides a practical approach to the diagnosis of pituitary specimens that are sent to the pathologist at the time of surgery. The initial examination requires routine haematoxylin and eosin staining to establish whether the lesion is a primary adenohypophysial proliferation or one of the many other pathologies that occurs in this area. The most common lesions resected surgically are pituitary adenomas. These are evaluated with several special stains and immunohistochemical markers that are now available to accurately classify these pathologies. The complex subclassification of pituitary adenomas is now recognised to reflect specific clinical features and genetic changes that predict targeted treatments for patients with pituitary disorders.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17142570      PMCID: PMC1860551          DOI: 10.1136/jcp.2005.031187

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  53 in total

1.  Craniopharyngiomas of adamantinomatous type harbor beta-catenin gene mutations.

Authors:  Shigeki Sekine; Tatsuhiro Shibata; Akiko Kokubu; Yukio Morishita; Masayuki Noguchi; Yukihiro Nakanishi; Michiie Sakamoto; Setsuo Hirohashi
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

Review 2.  POU-domain transcription factors: pou-er-ful developmental regulators.

Authors:  M G Rosenfeld
Journal:  Genes Dev       Date:  1991-06       Impact factor: 11.361

3.  NeuroD1/beta2 contributes to cell-specific transcription of the proopiomelanocortin gene.

Authors:  G Poulin; B Turgeon; J Drouin
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

4.  Metastatic cancer of the pituitary gland.

Authors:  K Kovacs
Journal:  Oncology       Date:  1973       Impact factor: 2.935

5.  Intrasellar malignant lymphoma developing within pituitary adenoma.

Authors:  D Kuhn; M Buchfelder; T Brabletz; W Paulus
Journal:  Acta Neuropathol       Date:  1999-03       Impact factor: 17.088

Review 6.  Pituitary lymphoma presenting as fever of unknown origin.

Authors:  R E Landman; S L Wardlaw; R J McConnell; A G Khandji; J N Bruce; P U Freda
Journal:  J Clin Endocrinol Metab       Date:  2001-04       Impact factor: 5.958

7.  Topoisomerase IIalpha expression in pituitary adenomas and carcinomas: relationship to tumor behavior.

Authors:  Sergio Vidal; Kalman Kovacs; Eva Horvath; Fabio Rotondo; Takao Kuroki; Ricardo V Lloyd; Bernd W Scheithauer
Journal:  Mod Pathol       Date:  2002-11       Impact factor: 7.842

8.  Metastatic tumors of the sella turcica masquerading as primary pituitary tumors.

Authors:  C L Branch; E R Laws
Journal:  J Clin Endocrinol Metab       Date:  1987-09       Impact factor: 5.958

9.  Pituitary thyrotroph hyperplasia mimicking prolactin-secreting adenoma.

Authors:  A Khalil; K Kovacs; A A Sima; G N Burrow; E Horvath
Journal:  J Endocrinol Invest       Date:  1984-08       Impact factor: 4.256

Review 10.  Intracranial germ-cell tumors: natural history and pathogenesis.

Authors:  M T Jennings; R Gelman; F Hochberg
Journal:  J Neurosurg       Date:  1985-08       Impact factor: 5.115

View more
  25 in total

Review 1.  Pathogenesis of pituitary tumors.

Authors:  Shlomo Melmed
Journal:  Nat Rev Endocrinol       Date:  2011-03-22       Impact factor: 43.330

2.  The Complementary Role of Transcription Factors in the Accurate Diagnosis of Clinically Nonfunctioning Pituitary Adenomas.

Authors:  Hiroshi Nishioka; Naoko Inoshita; Ozgur Mete; Sylvia L Asa; Kyohei Hayashi; Akira Takeshita; Noriaki Fukuhara; Mitsuo Yamaguchi-Okada; Yasuhiro Takeuchi; Shozo Yamada
Journal:  Endocr Pathol       Date:  2015-12       Impact factor: 3.943

3.  Null cell adenomas of the pituitary gland: an institutional review of their clinical imaging and behavioral characteristics.

Authors:  James A Balogun; Eric Monsalves; Kyle Juraschka; Kashif Parvez; Walter Kucharczyk; Ozgur Mete; Fred Gentili; Gelareh Zadeh
Journal:  Endocr Pathol       Date:  2015-03       Impact factor: 3.943

Review 4.  Clinical Impact of the Current WHO Classification of Pituitary Adenomas.

Authors:  W Saeger; J Honegger; M Theodoropoulou; U J Knappe; C Schöfl; S Petersenn; R Buslei
Journal:  Endocr Pathol       Date:  2016-06       Impact factor: 3.943

Review 5.  Headaches in Patients with Pituitary Tumors: a Clinical Conundrum.

Authors:  Laura E Donovan; Mary R Welch
Journal:  Curr Pain Headache Rep       Date:  2018-07-04

6.  Prevalence of double pituitary adenomas in a surgical series: Clinical, histological and genetic features.

Authors:  F Magri; C Villa; D Locatelli; P Scagnelli; M S Lagonigro; P Morbini; M Castellano; E Gabellieri; M Rotondi; E Solcia; A F Daly; L Chiovato
Journal:  J Endocrinol Invest       Date:  2009-12-01       Impact factor: 4.256

Review 7.  Sudden adult death.

Authors:  Neil E I Langlois
Journal:  Forensic Sci Med Pathol       Date:  2009-07-18       Impact factor: 2.007

8.  Monomorphous Plurihormonal Pituitary Adenoma of Pit-1 Lineage in a Giant Adolescent with Central Hyperthyroidism.

Authors:  Bernardo Dias Pereira; Luísa Raimundo; Ozgur Mete; Ana Oliveira; Jorge Portugal; Sylvia L Asa
Journal:  Endocr Pathol       Date:  2016-03       Impact factor: 3.943

Review 9.  [Sellar tumors].

Authors:  M-A Weber; S Zoubaa; M Politi; I Grunwald; M Essig
Journal:  Radiologe       Date:  2007-06       Impact factor: 0.635

10.  Silent familial isolated pituitary adenomas: histopathological and clinical case report.

Authors:  C Villa; F Magri; P Morbini; A Falchetti; P Scagnelli; E Lovati; D Locatelli; F R Canevari; V Necchi; E Gabellieri; G Guabello; L Chiovato; E Solcia
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.